Argent BioPharma Limited (ASX:RGT)
0.0460
+0.0020 (4.55%)
At close: Mar 6, 2026
-74.44% (1Y)
| Market Cap | 4.00M -46.0% |
| Revenue (ttm) | 347.78K +17.6% |
| Net Income | -8.62M |
| EPS | -0.12 |
| Shares Out | 86.94M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,818 |
| Average Volume | 72,216 |
| Open | 0.0450 |
| Previous Close | 0.0440 |
| Day's Range | 0.0450 - 0.0470 |
| 52-Week Range | 0.0440 - 0.3200 |
| Beta | 0.13 |
| RSI | 36.70 |
| Earnings Date | Feb 27, 2026 |